Nurix Therapeutics, Inc. (NRIX) Technical Analysis & Indicators

Nurix Therapeutics, Inc. (NRIX) — Price $25.70 (closing price, November 2, 2026) — Healthcare — Biotechnology — NASDAQ

Latest reported results:

Technical analysis of Nurix Therapeutics, Inc. (NRIX): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.

Nurix Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule and antibody therapies for the treatment of cancer, inflammatory conditions, and other diseases.

Price Performance

1 month+16.57%
3 months+8.55%
Year-to-date+41.28%
1 year+107.11%
3 years+314.86%
5 years-21.87%

52-Week Range

52-week High$28.23
52-week Low$11.50
Avg Volume (90d)1.6M

Technical Indicators

SMA 50$24.98
SMA 200$20.18
Beta1.98
30-day Volatility (annualised)42.6%
Price vs SMA 50+7.3%
Price vs SMA 200+32.8%

Monthly Close (12 months)

MonthCloseChange
2025-12$18.97
2026-01$16.52-12.9%
2026-02$15.97-3.3%
2026-03$15.50-2.9%
2026-04$16.70+7.7%
2026-05$17.76+6.3%
2026-06$24.26+36.6%
2026-07$23.21-4.3%
2026-08$25.78+11.1%
2026-09$23.71-8.0%
2026-10$26.80+13.0%

Upcoming Earnings

DateEPS Est.Revenue Est.
2027-02-17$-0.41$38M
2027-01-27$-0.46$38M
2026-10-12$-0.60$24M
2026-07-09$-0.72$15M
2026-04-08$-0.76$14M
2026-01-28$-0.84$13M
2025-10-09$-0.84$12M
2025-07-09$-0.71$18M

Price

Price$25.70 (closing price, November 2, 2026)
Market Cap$2.8B
ExchangeNASDAQ
CountryUS

Valuation Ratios

P/E Ratio11.13
Price / Book2.96
Dividend Yield0.00%

Financial Health

Debt / Equity0.07
Current Ratio8.44
Piotroski F-Score4
Altman Z-Score3.50

Related companies: RVMD · KYMR · TNGX · VRTX · 0QZU.L · REGN · MRNA · 0R2M.L

Explore sector: Healthcare · Biotechnology

More sections of NRIX: Overview · Financials · Valuation · Statistics · Estimates · Ownership · News · Events

Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method · Companies that pass the Lynch method · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks